BETA
Your AI-Trained Oncology Knowledge Connection!
Teclistamab Real-World Data and Trial Results Show Promise in R/R Multiple Myeloma
Experts discussed teclistamab's efficacy in multiple myeloma, highlighting real-world data and treatment protocols.
Long-Term Cilta-Cel Follow-Up Shows Curative Potential in Pretreated Multiple Myeloma
Cilta-cel shows promising long-term efficacy in treating relapsed/refractory multiple myeloma, with significant survival rates and manageable safety profiles.
Analyzing Long-Term Follow-Up Results From MonumenTAL-1 in Multiple Myeloma
Experts discussed talquetamab's unique mechanism and favorable patient outcomes in relapsed/refractory multiple myeloma.
Creating Space for Ide-Cel and Finding Sequencing Options in Multiple Myeloma
Experts debate cutting-edge multiple myeloma treatments, exploring pressing data, the most prominent news, and patient cases.
